Observational studyBMC surgery2026
Relationship between red blood cell transfusion and postoperative outcomes in patients undergoing coronary artery bypass grafting.
Observational study in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis single-center retrospective observational cohort study with propensity score adjustment was conducted to investigate the association between perioperative red blood cell (RBC) transfusion and short-term outcomes in patients undergoing isolated coronary artery bypass grafting (CABG).
methodsAdult patients who underwent isolated CABG at our center between September 30, 2021 and February 29, 2024 were included. Patients were divided into two groups: those who received RBC transfusion (RBC+ group) and those who did not (RBC- group) perioperatively. Propensity score matching (PSM) was used to minimize the influence of potential confounding factors between groups. The clinical outcomes, including composite infectious complications, composite ischemic events, and in-hospital mortality, were compared between groups.
resultsBefore PSM, 186 patients were included in the RBC+ group and 177 in the RBC- group. The RBC+ group had significantly higher rates of composite infectious complications, composite ischemic events, and in-hospital mortality than the RBC- group (all P < 0.001). After PSM (96 patients in each group), the RBC+ group still had significantly higher rates of composite infectious complications (P = 0.014) and composite ischemic events (P = 0.002) than the RBC- group; however, no statistically significant difference in in-hospital mortality was observed between the two groups (P = 0.155). In the RBC+ group, higher transfusion volumes were associated with a higher incidence of adverse clinical outcomes.
conclusionPerioperative RBC transfusion was associated with a higher incidence of adverse postoperative clinical outcomes in patients undergoing isolated CABG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.